Fidelis Capital Partners, LLC - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fidelis Capital Partners, LLC ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,845
-60.5%
38,5900.0%0.01%
-61.9%
Q2 2023$57,885
-10.7%
38,5900.0%0.02%
-25.0%
Q1 2023$64,831
+27.3%
38,5900.0%0.03%
-53.3%
Q4 2022$50,93938,5900.06%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NorthRock Partners, LLC 1,354,004$9,749,0000.80%
Shay Capital LLC 197,184$1,420,0000.18%
Corundum Group, Inc. 11,240$81,0000.06%
Mirae Asset Global Investments Co., Ltd. 1,132,131$8,151,0000.02%
Patriot Financial Group Insurance Agency, LLC 500$4,0000.00%
MORGAN STANLEY 668,151$4,811,0000.00%
WELLS FARGO & COMPANY/MN 2,956$21,0000.00%
NORTHERN TRUST CORP 56,561$407,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 279$2,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders